AtriCurevsEli Lilly and Company

ATRC and LLY stock compared: price, dividend, valuation and results, from SEC filings.

ATRC

AtriCure, Inc.

$55.85

Value $2.8B

+1.51%
ATRC's page

LLY

Eli Lilly and Company

$1,389.78

Value $1.31T

-1.82%
LLY's page

AtriCure (ATRC) has a market value of $2.8B and Eli Lilly and Company (LLY) $1.31T. Over the last year, with dividends, ATRC moved +68.6% and LLY +36.9%. The P/E is 186.9 for ATRC and 47.5 for LLY. Dividend yield: ATRC none, LLY 0.46%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ATRC$2.8B

    LLY$1.31T

    LLY is 471 times ATRC

  • Revenue, 12 months

    ATRC$590M

    LLY$86.5B

    LLY is 147 times ATRC

  • Net income, 12 months

    ATRC$15M

    LLY$27.6B

    LLY is 1,853 times ATRC

  • Operating margin

    ATRC2.9%

    LLY–

  • ROIC

    ATRC2.8%

    LLY35.5%

    32.7 points apart

  • P/E

    ATRC186.9

    LLY47.5

    ATRC is 3.9 times LLY

  • Dividend yield

    ATRC0.0%

    LLY0.5%

    0.5 points apart

  • 5-year return

    ATRC-28.7%

    LLY+455.6%

    484.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ATRC-28.7%

LLY+455.6%

020040060020222023202420252026
Returns by period
PeriodATRCWith dividendsLLYWith dividends
1 year since November 17, 2025+68.6%Price +68.6%+36.9%Price +36.0%
3 years since November 17, 2023+34.6%+10.4% a yearPrice +34.6%+139.6%+33.8% a yearPrice +134.9%
5 years since November 17, 2021-28.7%-6.5% a yearPrice -28.7%+455.6%+40.9% a yearPrice +432.1%
10 years since November 18, 2016+179.4%+10.8% a yearPrice +179.4%+2,008.6%+35.6% a yearPrice +1,712.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ATRCAtriCureLLYEli Lilly and Company

Valuation

ATRCLLY
Valuation
Price$55.85$1,389.78
Market value$2.8B$1.31T
Enterprise value (EV)$2.7B$1.36T
P/E186.947.5
P/E, 5-year median–49.9
P/B5.232.6
EV/EBIT157.639.0
Free cash flow yield1.9%1.5%

Results and growth

ATRCLLY
Results and growth
Revenue, 12 months$590M$86.5B
Net income, 12 months$15M$27.6B
Free cash flow, 12 months$53M$19.7B
Earnings per share, 12 months$0.30$30.81
Revenue growth, year on year14.9%44.7%
Revenue growth a year, past+21.0%over 5 years+21.6%over 5 years
EPS growth a year, past–+27.6%over 5 years

Margins and returns on capital

ATRCLLY
Margins and returns on capital
Gross margin76.7%83.6%
Operating margin2.9%–
Net margin2.5%31.9%
ROIC2.8%35.5%
ROE3.0%88.6%

Balance sheet

ATRCLLY
Balance sheet
Cash$187M$4.9B
Total debt$97M$49.5B
Net debt / EBITDA-3.31.2
Interest cover3.0×38.9×

Dividends and buybacks

ATRCLLY
Dividends and buybacks
Dividend yield–0.5%
Dividend per share, 12 months–$6.34
Dividend growth a year, past–+15.2%over 5 years
Buyback yield–0.3%
Shareholder yield–0.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ATRC or LLY

Didn't find what you were looking for?

Ask us
Which is bigger, AtriCure or Eli Lilly and Company?

By market value, Eli Lilly and Company ($1.31T) is about 471.3 times AtriCure ($2.8B), at today's prices.

How did ATRC and LLY stock do over the last 10 years?

Since November 18, 2016, ATRC's price moved +179.4% and LLY's +1,712.7%. With dividends: ATRC +179.4% (+10.8% a year), LLY +2,008.6% (+35.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, ATRC or LLY?

The dividend yield at today's price is none for AtriCure and 0.46% for Eli Lilly and Company. Over the last twelve months they paid – and $6.34 per share.

What is the P/E of ATRC and LLY?

At today's price, the P/E is 186.9 for ATRC and 47.5 for LLY. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, AtriCure or Eli Lilly and Company?

Over the last twelve months, the net margin was 2.5% for AtriCure and 31.9% for Eli Lilly and Company, and the operating margin 2.9% and –. Revenue was $590M and $86.5B.

Which is the better investment, AtriCure or Eli Lilly and Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.